Human embryonic kidney (HEK293) cells are commonly used in the production of biopharmaceuticals for their reliable growth in culture, high transfectivity, and ability to grow in a serum-free, suspension culture. Cell line-specific requirements for nutrients and/or growth factors can dramatically decrease productivity during the key steps of growth and production. As a result, considerable and costly media optimization is often required when moving to commercial scale.
Contained in this HEK293 media portfolio are chemically defined, serum-free, animal component-free, and hydrolysates-free solutions designed and optimized to support high-density suspension culture of HEK293 and other human cell lines. This portfolio maximizes productivity across various applications, including the production of recombinant proteins as well as viral vectors for gene therapy and vaccines. Explore comprehensive, all-in-one solutions for infection and transfection of a wide range of HEK293 in suspension culture.